KRISHGEN BioSystems Drug discovery > Pre-Clinical Development Products & Reviews

Enzyme Immunoassay for the Quantitative Determination of Faricimab in human serum and plasma.

Enzyme Immunoassay for the quantitative determination of Ocrelizumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Pidilizumab in serum and plasma.

Enzyme Immunoassay for the Quantitative Determination of Relatlimab in human serum and plasma

Enzyme Immunoassay for the Quantitative Determination of Teclistamab in serum and plasma

Quantitative immunoassay for Ustekinumab

Enzyme Immunoassay for the quantitative determination of Erenumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Guselkumab in serum and plasma.

Enzyme Immunoassay for the Quantitative Determination of Cemiplimab in human serum and plasma

Enzyme Immunoassay for the Quantitative Determination of Amivantamab in serum and plasma

Canakinumab (ILARIS) ELISA for quantitative determination of Canakinumab (ILARIS) in human serum

Enzyme Immunoassay for the Quantitative Determination of Teprotumumab in serum and plasma.

ELISA for the detection of Mosunetuzumab in human serum and plasma.

Enzyme Immunoassay for the Quantitative Determination of Darbepoetin in human serum and plasma

Enzyme Immunoassay for the quantitative determination of Nilotinib in serum, plasma and cell culture supernatant

Enzyme Immunoassay for the Quantitative Determination of Dasatinib in human serum and plasma

Enzyme Immunoassay for the quantitative determination of Golimumab in serum, plasma and cell culture supernatant

Enzyme Immunoassay for the quantitative determination of Necitumumab in serum and plasma.

Immunoassay for quantitative estimation of Cafilzomib in human serum and plasma.

Immunoassay for the quantitative determination of Ustekinumab in human serum and plasma

Enzyme Immunoassay for the quantitative determination of Denosumab (PROLIA) in serum, plasma and cell culture supernatant

Enzyme Immunoassay for the quantitative determination of Vedolizumab (ENTYVIO) in serum, plasma and cell culture supernatant

The Eculizumab (Soliris) ELISA kit is intended for the quantitative determination of Eculizumab (Soliris) in serum, plasma and cell culture samples. CE IVD marked. Key features: -uses highly specific monoclonal anti-idiotypic antibodies -calibrator used is commerically available eculizumab injection itself -Recovery: 80-120% -Precision CV

Enzyme Immunoassay for the quantitative determination of Ixekizumab in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Secukinumab in serum and plasma.